SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Early Out who wrote (7457)4/25/1998 9:44:00 PM
From: VLAD  Read Replies (2) | Respond to of 23519
 
Short interest on Vivus as of April 15: 11,456,890 up 6% from March

Source: Barrons



To: Early Out who wrote (7457)4/25/1998 10:00:00 PM
From: Rashid Garuba  Read Replies (1) | Respond to of 23519
 
Have not much experience with VVUS, but it's trading on future sales at this point. Not knocking Viagra, but it seems true new wonder drugs with no side effects are few and far between. Reminds me of the Redux Saga. Time will tell with Muse and Viagra.

Rashid


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News